420 related articles for article (PubMed ID: 34961453)
21. Gut microbiota derived metabolites in cardiovascular health and disease.
Wang Z; Zhao Y
Protein Cell; 2018 May; 9(5):416-431. PubMed ID: 29725935
[TBL] [Abstract][Full Text] [Related]
22. Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease.
Ahmed S; Spence JD
Biol Sex Differ; 2021 May; 12(1):35. PubMed ID: 34001264
[TBL] [Abstract][Full Text] [Related]
23. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.
Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904
[TBL] [Abstract][Full Text] [Related]
24. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
25. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota and cardiovascular diseases axis.
Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
[TBL] [Abstract][Full Text] [Related]
27. Gut Microbiota in Cardiovascular Health and Disease.
Tang WH; Kitai T; Hazen SL
Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349
[TBL] [Abstract][Full Text] [Related]
28. Gut Microbiota and Cardiovascular Diseases: A Critical Review.
Anselmi G; Gagliardi L; Egidi G; Leone S; Gasbarrini A; Miggiano GAD; Galiuto L
Cardiol Rev; 2021 Jul-Aug 01; 29(4):195-204. PubMed ID: 32639240
[TBL] [Abstract][Full Text] [Related]
29. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC
Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291
[TBL] [Abstract][Full Text] [Related]
30. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
31. Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review.
Tang WHW; Bäckhed F; Landmesser U; Hazen SL
J Am Coll Cardiol; 2019 Apr; 73(16):2089-2105. PubMed ID: 31023434
[TBL] [Abstract][Full Text] [Related]
32. Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases.
Tan J; Taitz J; Nanan R; Grau G; Macia L
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894934
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Microbiome in Heart Failure.
Kitai T; Kirsop J; Tang WH
Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
[TBL] [Abstract][Full Text] [Related]
34. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.
Yeh CF; Chen YH; Liu SF; Kao HL; Wu MS; Yang KC; Wu WK
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227973
[TBL] [Abstract][Full Text] [Related]
35. Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases.
Garg Y; Kanwar N; Chopra S; Tambuwala MM; Dodiya H; Bhatia A; Kanwal A
Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1344-1356. PubMed ID: 35761484
[TBL] [Abstract][Full Text] [Related]
36. Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship.
Nesci A; Carnuccio C; Ruggieri V; D'Alessandro A; Di Giorgio A; Santoro L; Gasbarrini A; Santoliquido A; Ponziani FR
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240434
[TBL] [Abstract][Full Text] [Related]
37. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
[TBL] [Abstract][Full Text] [Related]
38. Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.
Anwar S; Bhandari U; Panda BP; Dubey K; Khan W; Ahmad S
J Pharm Biomed Anal; 2018 Sep; 159():100-112. PubMed ID: 29980011
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?
He M; Tan CP; Xu YJ; Liu Y
Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187
[TBL] [Abstract][Full Text] [Related]
40. A Multi-omic Association Study of Trimethylamine N-Oxide.
Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
